Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Orunesu

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Endocrinological Investigation|February 27, 2003
Abnormal bone scintigraphy and acute-onset severe primary hyperparathyroidismL dell'Erba, S Palermo, E Orunesu, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 20, 2010
Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticalsE Bombardieri, A Coliva, M Maccauro, et al.
Journal of Clinical Pathology|March 30, 2004
Analytical and diagnostic accuracy of "second generation" assays for thyrotrophin receptor antibodies with radioactive and chemiluminescent tracersD Villalta, E Orunesu, R Tozzoli, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|December 18, 2008
MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?M R Castellani, E Seregni, M Maccauro, et al.
European Journal of Clinical Investigation|March 18, 2004
Use of an artificial neural network to predict Graves' disease outcome within 2 years of drug withdrawalE Orunesu, M Bagnasco, C Salmaso, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 20, 2010
(131)I-MIBG treatment of pheochromocytoma: low versus intermediate activity regimens of therapyM R Castellani, S Seghezzi, C Chiesa, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|November 14, 2009
Individualized dosimetry in the management of metastatic differentiated thyroid cancerC Chiesa, M R Castellani, C Vellani, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Endocrinological Investigation|February 27, 2003
Abnormal bone scintigraphy and acute-onset severe primary hyperparathyroidismL dell'Erba, S Palermo, E Orunesu, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 20, 2010
Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticalsE Bombardieri, A Coliva, M Maccauro, et al.
Journal of Clinical Pathology|March 30, 2004
Analytical and diagnostic accuracy of "second generation" assays for thyrotrophin receptor antibodies with radioactive and chemiluminescent tracersD Villalta, E Orunesu, R Tozzoli, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|December 18, 2008
MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?M R Castellani, E Seregni, M Maccauro, et al.
European Journal of Clinical Investigation|March 18, 2004
Use of an artificial neural network to predict Graves' disease outcome within 2 years of drug withdrawalE Orunesu, M Bagnasco, C Salmaso, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 20, 2010
(131)I-MIBG treatment of pheochromocytoma: low versus intermediate activity regimens of therapyM R Castellani, S Seghezzi, C Chiesa, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|November 14, 2009
Individualized dosimetry in the management of metastatic differentiated thyroid cancerC Chiesa, M R Castellani, C Vellani, et al.
Pageof 1